Imuno is a biotechnology company focused on developing precision immunotherapies for hard-to-treat cancers. Utilizing their proprietary TACTICSTM technology, they engineer antibodies that specifically target cancer antigens presented by MHC molecules, ensuring potent therapies while sparing healthy tissues. Their innovative approach aims to transform cancer treatment by identifying safe targets and advancing a pipeline of therapies against novel antigens across multiple indications. With a dedicated team of scientists and a commitment to ethical excellence, Imuno is positioned to make a significant impact in the field of cancer immunotherapy.
Something looks off?